Proposed Data Collections Submitted for Public Comment and Recommendations, 75966-75967 [E6-21584]
Download as PDF
<![CDATA[
75966
Federal Register / Vol. 71, No. 243 / Tuesday, December 19, 2006 / Notices
FEDERAL RESERVE SYSTEM
FEDERAL RESERVE SYSTEM
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
Notice of Proposals to Engage in
Permissible Nonbanking Activities or
to Acquire Companies that are
Engaged in Permissible Nonbanking
Activities
hsrobinson on PROD1PC76 with NOTICES
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR Part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The application also will be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Additional information on all bank
holding companies may be obtained
from the National Information Center
website at www.ffiec.gov/nic/.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than January 16,
2007.
A. Federal Reserve Bank of
Richmond (A. Linwood Gill, III, Vice
President) 701 East Byrd Street,
Richmond, Virginia 23261–4528:
1. Sandy Spring Bancorp, Inc., Olney,
Maryland; to acquire 100 percent of the
voting shares of Potomac Bank of
Virginia, Fairfax, Virginia.
Board of Governors of the Federal Reserve
System, December 14, 2006.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. E6–21598 Filed 12–18–06; 8:45 am]
BILLING CODE 6210–01–S
The companies listed in this notice
have given notice under section 4 of the
Bank Holding Company Act (12 U.S.C.
1843) (BHC Act) and Regulation Y (12
CFR Part 225) to engage de novo, or to
acquire or control voting securities or
assets of a company, including the
companies listed below, that engages
either directly or through a subsidiary or
other company, in a nonbanking activity
that is listed in § 225.28 of Regulation Y
(12 CFR 225.28) or that the Board has
determined by Order to be closely
related to banking and permissible for
bank holding companies. Unless
otherwise noted, these activities will be
conducted throughout the United States.
Each notice is available for inspection
at the Federal Reserve Bank indicated.
The notice also will be available for
inspection at the offices of the Board of
Governors. Interested persons may
express their views in writing on the
question whether the proposal complies
with the standards of section 4 of the
BHC Act. Additional information on all
bank holding companies may be
obtained from the National Information
Center website at www.ffiec.gov/nic/.
Unless otherwise noted, comments
regarding the applications must be
received at the Reserve Bank indicated
or the offices of the Board of Governors
not later than January 12, 2007.
A. Federal Reserve Bank of Chicago
(Patrick M. Wilder, Assistant Vice
President) 230 South LaSalle Street,
Chicago, Illinois 60690-1414:
1. Heartland Bancorp, Inc.,
Bloomington, Illinois; to acquire 100
percent of the voting shares of First
Federal Bancshares, Colchester, Illinois,
and thereby indirectly acquire First
Federal Bank, Colchester, Illinois, and
engage in operating a savings and loan
association, pursuant to section
225.28(b)(4)(ii) of Regulation Y.
Board of Governors of the Federal Reserve
System, December 13, 2006.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. E6–21547 Filed 12–18–06; 8:45 am]
BILLING CODE 6210–01–S
VerDate Aug<31>2005
17:07 Dec 18, 2006
Jkt 211001
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–07–0527]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–4766 or send
comments to Seleda Perryman, CDC
Assistant Reports Clearance Officer,
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Human Exposure to Cyanobacterial
(blue-green algal) Toxins in Drinking
Water: Risk of Exposure to Microcystin
from Public Water Systems (OMB No.
0920–0527)-Extension-National Center
for Environmental Health (NCEH),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Cyanobacteria (blue-green algae) can
be found in terrestrial, fresh, brackish,
or marine water environments. Some
species of cyanobacteria produce toxins
that may cause acute or chronic
illnesses (including neurotoxicity,
hepatotoxicity, and skin irritation) in
humans and animals (including other
mammals, fish, and birds). A number of
human health effects, including
gastroenteritis, respiratory effects, skin
E:\FR\FM\19DEN1.SGM
19DEN1
75967
Federal Register / Vol. 71, No. 243 / Tuesday, December 19, 2006 / Notices
irritations, allergic responses, and liver
damage, are associated with the
ingestion of or contact with water
containing cyanobacterial blooms.
Although the balance of evidence, in
conjunction with data from laboratory
animal research, suggests that
cyanobacterial toxins are responsible for
a range of human health effects, there
have been few epidemiologic studies of
this association.
CDC plans to recruit 100 people
whose tap water comes from a source
with a current cyanobaterial bloom (i.e.,
M. aeruginosa) and who report drinking
unfiltered tap water. We also plan to
recruit 100 people who report drinking
unfiltered tap water but whose tap water
source is groundwater that is not
contaminated with cyanobacteria. This
population will serve as our referent
population for the analysis of
microcystins in blood and for the
clinical assays. We will administer a
questionnaire and collect blood samples
from all study participants. Blood
samples will be analyzed using a newly
developed molecular assay for levels of
microcystins, the hepatotoxin produced
by Micocystis aeruginosa. We also will
analyze blood samples for levels of liver
enzymes (a biological marker of
hepatotoxicity) and for a number of
clinical parameters including hepatitis
infection (a potential confounder in our
study). We will evaluate whether we
can (1) Detect low levels of microcystins
(<10 ng/ml of blood), in the blood of
people who are exposed to very low
levels of this toxin in their drinking
water and (2) Utilize clinical endpoints
such as blood liver enzyme levels as
biomarkers of exposure and biological
effect, and (3) Compare the analytical
results for the exposed population with
the results from the referent population.
CDC is working with a group of utility
companies that are interested in the
project and plan to discuss
implementation logistics early in 2007.
There are no costs to respondents except
their time to participate in the survey.
ESTIMATED ANNUALIZED BURDEN HOURS
No. of respondents
Respondents
Telephone Contact ..........................................................................................
Interview ...........................................................................................................
Blood Samples Collection ................................................................................
Tap Water Sample Collection ..........................................................................
Total ..........................................................................................................
Dated: December 13, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E6–21584 Filed 12–18–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: December 12, 2006.
Michelle Shortt,
Director, Regulations Development Group,
Office of Strategic Operations and Regulatory
Affairs.
[FR Doc. 06–9786 Filed 12–15–06; 1:45 pm]
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–367]
BILLING CODE 4120–01–P
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request; Partial
Retraction
ACTION:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Notice, partial retraction
SUMMARY: On Friday, November 24,
2006 (71 FR 67873), the Centers of
Medicare & Medicaid Services (CMS)
published a Notice document titled
‘‘Agency Information Collection
Activities; Proposed Collection;
Comment Request’’. That notice invited
public comments on three separate
hsrobinson on PROD1PC76 with NOTICES
300
200
200
200
information collections. Through the
publication of this document, CMS is
retracting the portion of that notice
requesting public comment on the
Information Collection Requirement
titled ‘‘Medicaid Drug Program Monthly
Quarterly Drug Reporting Format’’, form
number CMS–367 (OMB # 0938–0578).
Administration for Children and
Families
Proposed Information Collection
Activity; Comment Request
Proposed Projects
Title: Federal Tax Offset,
Administrative Offset, and Passport
Denial Program.
Average burden per response
(in hours)
No. of responses per
respondent
1
1
1
1
10/60
1
20/60
30/60
Total Burden
(in hours)
50
200
67
100
417
OMB No.: 0970–0161.
Description: The Tax Refund Offset
and Administrative Offset Programs
collect past-due child support by
intercepting certain Federal payments,
including Federal tax refunds, of
parents who have been ordered to pay
child support and who are behind in
paying the debt. The program is a
cooperative effort among the
Department of Treasury’s Financial
Management Service (FMS), the Federal
Office of Child Support Enforcement
(OCSE), and State Child Support
Enforcement (CSE) agencies. The
Passport Denial program reports noncustodial parents who owe arrears above
a threshold to the Department of State
(DOS), which will then deny passports
to these individuals. On an ongoing
basis, CSE agencies submit to OCSE the
names, Social Security numbers (SSNs),
and the amount(s) of past-due child
support of people who are delinquent in
making child support payments.
Respondents: State IV–D Agencies.
ANNUAL BURDEN ESTIMATES
Number of respondents
Instrument
Number of responses per
respondent
Average burden hours per
response
54
52
.3
Input Record ....................................................................................................
VerDate Aug<31>2005
17:07 Dec 18, 2006
Jkt 211001
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
E:\FR\FM\19DEN1.SGM
19DEN1
Total burden
hours
842
]]>Agencies
[Federal Register Volume 71, Number 243 (Tuesday, December 19, 2006)]
[Notices]
[Pages 75966-75967]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-21584]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-07-0527]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-4766 or
send comments to Seleda Perryman, CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail
to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Human Exposure to Cyanobacterial (blue-green algal) Toxins in
Drinking Water: Risk of Exposure to Microcystin from Public Water
Systems (OMB No. 0920-0527)-Extension-National Center for Environmental
Health (NCEH), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Cyanobacteria (blue-green algae) can be found in terrestrial,
fresh, brackish, or marine water environments. Some species of
cyanobacteria produce toxins that may cause acute or chronic illnesses
(including neurotoxicity, hepatotoxicity, and skin irritation) in
humans and animals (including other mammals, fish, and birds). A number
of human health effects, including gastroenteritis, respiratory
effects, skin
[[Page 75967]]
irritations, allergic responses, and liver damage, are associated with
the ingestion of or contact with water containing cyanobacterial
blooms. Although the balance of evidence, in conjunction with data from
laboratory animal research, suggests that cyanobacterial toxins are
responsible for a range of human health effects, there have been few
epidemiologic studies of this association.
CDC plans to recruit 100 people whose tap water comes from a source
with a current cyanobaterial bloom (i.e., M. aeruginosa) and who report
drinking unfiltered tap water. We also plan to recruit 100 people who
report drinking unfiltered tap water but whose tap water source is
groundwater that is not contaminated with cyanobacteria. This
population will serve as our referent population for the analysis of
microcystins in blood and for the clinical assays. We will administer a
questionnaire and collect blood samples from all study participants.
Blood samples will be analyzed using a newly developed molecular assay
for levels of microcystins, the hepatotoxin produced by Micocystis
aeruginosa. We also will analyze blood samples for levels of liver
enzymes (a biological marker of hepatotoxicity) and for a number of
clinical parameters including hepatitis infection (a potential
confounder in our study). We will evaluate whether we can (1) Detect
low levels of microcystins (<10 ng/ml of blood), in the blood of people
who are exposed to very low levels of this toxin in their drinking
water and (2) Utilize clinical endpoints such as blood liver enzyme
levels as biomarkers of exposure and biological effect, and (3) Compare
the analytical results for the exposed population with the results from
the referent population.
CDC is working with a group of utility companies that are
interested in the project and plan to discuss implementation logistics
early in 2007. There are no costs to respondents except their time to
participate in the survey.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
No. of Average burden
Respondents No. of responses per per response Total Burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Telephone Contact............................... 300 1 10/60 50
Interview....................................... 200 1 1 200
Blood Samples Collection........................ 200 1 20/60 67
Tap Water Sample Collection..................... 200 1 30/60 100
Total....................................... .............. .............. .............. 417
----------------------------------------------------------------------------------------------------------------
Dated: December 13, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E6-21584 Filed 12-18-06; 8:45 am]
BILLING CODE 4163-18-P
